The global insulin delivery devices market is experiencing strong expansion as the prevalence of diabetes continues to rise worldwide. Insulin delivery devices play a crucial role in managing blood ...
(1,2) "Awiqli (R) is an important new option that meets a real need as the first FDA-approved, once-weekly basal insulin for adult patients with type 2 diabetes. It's helping to reframe what basal ...
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...
Diabetes Care Devices Market Insights, Competitive Landscape, and Market Forecast - 2034” report provides the current ...
A Provo jury on Tuesday convicted former Santaquin nurse Meggan Sundwall of manslaughter and obstruction of justice, deciding she used insulin to kill her friend, Kacee Lyn Terry, in Highland in ...
At the Blue Jays’ player development complex, you may see prospect Aaron Parker walking around with a brown leather fanny ...
Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae) injection 700 units/mL, the first and only once-weekly, long-acting basal insulin ...
Half of US generic drugs are made in India and transit the Strait of Hormuz. Supply chains prepare for emergencies, but ...
Morning Overview on MSN
The biggest GLP-1 drug mistake, and how to avoid it
The FDA has spent much of 2025 issuing warnings about a single, recurring problem with GLP-1 weight loss drugs: patients and ...
‘I bought weight loss jabs on social media – this is why I regret it’ - Doctor warns buying weight loss drugs from illegitimate sources like social media could be ‘life-threatening’ ...
'Do you think you're going to be the one dumb, ugly, tired person?' Inside a San Francisco startup's quest for peptide dominance.
ITV's Tonight programme has been told there are believed to be over one million performance-enhancing drug and anabolic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results